HIROTSU BIO SCIENCE INC. recently increased its capital through the allocation of new shares to third parties. To deliver N-NOSE, a new method that can speed up the detection and treatment of cancer, to many others, we will work to build awareness while also strengthening our test supply system.
On Thursday, March 16, "DAVOS 2023 DEBRIEFING" was held by the Consulate of Switzerland in Osaka.Our CMO/CGO, Shunsuke Mizushima, was invited as . . .2023.03.20
HIROTSU BIO SCIENCE releases a cancer screening for “Pet Dogs”. “N-NOSE Dogs” Website now available. －Pre-order available, special discounts ar . . .2023.03.10
Our CEO made a courtesy call on Minister Yasutoshi Nishimura.2023.02.27